AU2002211999A1 - Haemophilus influenzae antigens and corresponding DNA fragments - Google Patents

Haemophilus influenzae antigens and corresponding DNA fragments

Info

Publication number: AU2002211999A1
Authority: AU; Australia
Prior art keywords: polypeptide; seq; polynucleotide; nos; fragments
Prior art date: 2000-10-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002211999A

Other languages

English (en)

Inventor

Bernard R Brodeur

Annie Charbonneau

France Couture

Josee Hamel

Denis Martin

Catherine Ouellet

Mireille Tremblay

Catherine Vayssier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ID Biomedical Corp of Quebec

Original Assignee

Shire BioChem Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-02

Filing date

2001-10-02

Publication date

2002-04-15

2001-10-02 Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc

2002-04-15 Publication of AU2002211999A1 publication Critical patent/AU2002211999A1/en

2007-05-31 Assigned to ID BIOMEDICAL CORPORATION reassignment ID BIOMEDICAL CORPORATION Request for Assignment Assignors: SHIRE BIOCHEM INC.

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Virology (AREA)
Mycology (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2002211999A 2000-10-02 2001-10-02 Haemophilus influenzae antigens and corresponding DNA fragments Abandoned AU2002211999A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US23671200P	2000-10-02	2000-10-02
US60/236,712		2000-10-02
PCT/CA2001/001402 WO2002028889A2 (en)	2000-10-02	2001-10-02	Haemophilus influenzae antigens and corresponding dna fragments

Publications (1)

Publication Number	Publication Date
AU2002211999A1 true AU2002211999A1 (en)	2002-04-15

Family

ID=22890628

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002211999A Abandoned AU2002211999A1 (en)	2000-10-02	2001-10-02	Haemophilus influenzae antigens and corresponding DNA fragments

Country Status (13)

Country	Link
US (1)	US20040171802A1 (da)
EP (4)	EP1322762A2 (da)
JP (3)	JP2004509647A (da)
AU (1)	AU2002211999A1 (da)
BR (1)	BR0114403A (da)
CA (1)	CA2424275A1 (da)
CY (2)	CY1114614T1 (da)
DK (2)	DK2270171T5 (da)
ES (2)	ES2588023T3 (da)
HK (1)	HK1152965A1 (da)
PT (2)	PT2270171E (da)
SI (2)	SI2270171T1 (da)
WO (1)	WO2002028889A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004018514A1 (en) *	2002-08-22	2004-03-04	Id Biomedical Corporation	Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments
GB0410866D0 (en)	2004-05-14	2004-06-16	Chiron Srl	Haemophilius influenzae
ES2310062B1 (es) *	2005-07-15	2009-11-13	Bionostra, S.L.	Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
EP2548884B1 (en)	2005-08-10	2017-08-02	Arne Forsgren AB	Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system
US8617565B2 (en) *	2006-01-17	2013-12-31	Arne Forsgren et al.	Surface exposed Haemophilus influenzae protein (protein E; pE)
TW201302779A (zh)	2011-04-13	2013-01-16	Glaxosmithkline Biolog Sa	融合蛋白質及組合疫苗
WO2013160335A2 (en) *	2012-04-26	2013-10-31	Novartis Ag	Antigens and antigen combinations
US10279026B2 (en) *	2012-04-26	2019-05-07	Glaxosmithkline Biologicals Sa	Antigens and antigen combinations
EP3302404B1 (en)	2015-06-05	2022-09-28	Firmenich SA	Microcapsules with high deposition on surfaces

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4425437A (en)	1979-11-05	1984-01-10	Genentech, Inc.	Microbial polypeptide expression vehicle
US4431739A (en)	1979-11-05	1984-02-14	Genentech, Inc.	Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en)	1980-04-11	1982-07-06	President And Fellows Of Harvard College	Mature protein synthesis
EP0821737A4 (en) *	1995-04-21	2005-01-19	Human Genome Sciences Inc	NUCLEOTIDE SEQUENCE OF THE GENOME HAEMOPHILUS INFLUENZAE RD, THE FRAGMENTS THEREOF, AND ITS APPLICATIONS
GB9513074D0 (en) *	1995-06-27	1995-08-30	Cortecs Ltd	Novel anigen
CA2671261A1 (en)	1997-11-06	1999-05-20	Novartis Vaccines And Diagnostics S.R.L.	Neisserial antigens

2001
- 2001-10-02 DK DK10177857.9T patent/DK2270171T5/da active
- 2001-10-02 PT PT101778579T patent/PT2270171E/pt unknown
- 2001-10-02 US US10/398,186 patent/US20040171802A1/en not_active Abandoned
- 2001-10-02 CA CA002424275A patent/CA2424275A1/en not_active Abandoned
- 2001-10-02 EP EP01980063A patent/EP1322762A2/en not_active Withdrawn
- 2001-10-02 AU AU2002211999A patent/AU2002211999A1/en not_active Abandoned
- 2001-10-02 BR BR0114403-0A patent/BR0114403A/pt not_active Application Discontinuation
- 2001-10-02 SI SI200131030T patent/SI2270171T1/sl unknown
- 2001-10-02 EP EP10177857.9A patent/EP2270171B1/en not_active Expired - Lifetime
- 2001-10-02 WO PCT/CA2001/001402 patent/WO2002028889A2/en active Application Filing
- 2001-10-02 JP JP2002532471A patent/JP2004509647A/ja not_active Withdrawn
- 2001-10-02 EP EP09159896.1A patent/EP2088197B8/en not_active Expired - Lifetime
- 2001-10-02 ES ES09159896.1T patent/ES2588023T3/es not_active Expired - Lifetime
- 2001-10-02 EP EP10177862A patent/EP2280071A3/en not_active Withdrawn
- 2001-10-02 ES ES10177857T patent/ES2435923T3/es not_active Expired - Lifetime
- 2001-10-02 PT PT91598961T patent/PT2088197T/pt unknown
- 2001-10-02 SI SI200131055A patent/SI2088197T1/sl unknown
- 2001-10-02 DK DK09159896.1T patent/DK2088197T3/da active
2008
- 2008-12-16 JP JP2008320133A patent/JP2009149642A/ja active Pending
2011
- 2011-05-31 JP JP2011121415A patent/JP2011231114A/ja active Pending
- 2011-07-05 HK HK11106917.4A patent/HK1152965A1/xx not_active IP Right Cessation
2013
- 2013-10-31 CY CY20131100967T patent/CY1114614T1/el unknown
2016
- 2016-07-07 CY CY20161100642T patent/CY1117746T1/el unknown

Also Published As

Publication number	Publication date
US20040171802A1 (en)	2004-09-02
DK2088197T3 (da)	2016-08-01
EP2270171A3 (en)	2011-04-27
DK2270171T5 (da)	2013-11-18
EP1322762A2 (en)	2003-07-02
EP2280071A2 (en)	2011-02-02
ES2435923T3 (es)	2013-12-26
WO2002028889A2 (en)	2002-04-11
EP2270171A2 (en)	2011-01-05
SI2088197T1 (sl)	2016-11-30
EP2088197A2 (en)	2009-08-12
CA2424275A1 (en)	2002-04-11
JP2011231114A (ja)	2011-11-17
CY1114614T1 (el)	2016-10-05
EP2280071A3 (en)	2011-04-27
BR0114403A (pt)	2004-02-17
PT2270171E (pt)	2013-11-05
JP2009149642A (ja)	2009-07-09
EP2088197A3 (en)	2011-12-21
ES2588023T3 (es)	2016-10-28
DK2270171T3 (da)	2013-10-14
EP2088197B8 (en)	2016-07-20
CY1117746T1 (el)	2017-05-17
EP2088197B1 (en)	2016-06-08
EP2270171B1 (en)	2013-09-04
SI2270171T1 (sl)	2013-12-31
PT2088197T (pt)	2016-08-01
HK1152965A1 (en)	2012-03-16
WO2002028889A3 (en)	2003-04-10
JP2004509647A (ja)	2004-04-02

Publication	Publication Date	Title
JP2011231114A (ja)	2011-11-17	ヘモフィルス・インフルエンゼ抗原及び対応ｄｎａ断片
US20090074807A1 (en)	2009-03-19	Moraxella (branhamella) catarrhalis antigens
AU2007202270B8 (en)	2011-10-13	Haemophilus influenzae antigens and corresponding DNA fragments
AU2011253696B8 (en)	2014-02-20	Haemophilus influenzae antigens and corresponding DNA fragments
AU2002302236A1 (en)	2003-05-01	Moraxella(Branhamella) catarrhalis antigens
EP1399563B1 (en)	2009-01-21	Moraxella (branhamella) catarrhalis antigens
US7329500B2 (en)	2008-02-12	Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments
US7410648B2 (en)	2008-08-12	Polypeptides of Moraxella (Branhamella) catarrhalis
AU2002325109A1 (en)	2003-06-05	Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments
AU2002344869A1 (en)	2003-01-02	Moraxella (branhamella) catarrhalis antigens
WO2004018514A1 (en)	2004-03-04	Polypeptides of nontypeable haemophilus influenzae and corresponding dna fragments
WO2004009621A2 (en)	2004-01-29	Polypeptides of nontypeable haemophilus influenzae

Legal Events

Date	Code	Title	Description
2007-05-31	PC1	Assignment before grant (sect. 113)	Owner name: ID BIOMEDICAL CORPORATION Free format text: FORMER APPLICANT(S): SHIRE BIOCHEM INC.
2007-06-14	MK5	Application lapsed section 142(2)(e) - patent request and compl. specification not accepted

Date

Code

Title

Description

2007-05-31

PC1

Assignment before grant (sect. 113)

Owner name: ID BIOMEDICAL CORPORATION

Free format text: FORMER APPLICANT(S): SHIRE BIOCHEM INC.

2007-06-14

MK5

Application lapsed section 142(2)(e) - patent request and compl. specification not accepted